-
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
(PAR-24-172)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): Multiple dates, see announcement.
-
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
(PAR-24-173)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): Multiple dates, see announcement.
-
Mechanistic and Hemodynamic Basis of Diffuse White Matter Disease in Vascular Contributions to Cognitive Impairment and Dementia (VCID)(R01 - Clinical Trial Not Allowed)
(PAR-24-196)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
Application Receipt Date(s): October 04, 2024
-
Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)
(PAR-24-206)
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): Multiple dates, see announcement.
-
Immunobiology of Xenotransplantation (U01 Clinical Trial Not Allowed)
(RFA-AI-24-019)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): Multiple dates, see announcement.
-
Immunobiology of Xenotransplantation (U19 Clinical Trial Not Allowed)
(RFA-AI-24-020)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): Multiple dates, see announcement.
-
Partnerships for the Development of Tools to Advance Therapeutic Discovery for Select Antibiotic-Resistant Gram-Negative Bacteria (R01 Clinical Trial Not Allowed)
(RFA-AI-24-021)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): Multiple dates, see announcement.
-
Discovery of Early Type 1 Diabetes Disease Processes in the Human Pancreas [HIRN Consortium on Beta Cell Death and Survival (CBDS)] (U01 Clinical Trial Not Allowed)
(RFA-DK-23-007)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): Multiple dates, see announcement.
-
Adaptation of Diabetes Control Technologies for Older Adults with T1D (R01 Clinical Trial Optional)
(RFA-DK-24-002)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): Multiple dates, see announcement.
-
Diabetes Research Centers (P30 Clinical Trial Optional)
(RFA-DK-25-008)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): June 18, 2024
-
Kidney Technology Development Research Education Program (R25 - Independent Clinical Trial Not Allowed)
(RFA-DK-25-009)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): Multiple dates, see announcement.
-
Convener and Organizer of Activities and Engagements Related to Processes, Surveillance, and Policy Development of Medical Products for Ongoing Public Health Activities, U01 Clinical Trial Not Allowed
(RFA-FD-24-036)
Food and Drug Administration
Application Receipt Date(s): June 17, 2024
-
Medical Rehabilitation Research Resource (P50 Clinical Trial Optional)
(RFA-HD-25-001)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Institute of Biomedical Imaging and Bioengineering
Application Receipt Date(s): Multiple dates, see announcement.
-
Precision Mental Health: Develop Tools to Inform Treatment Selection in Depression (UG3/UH3 Clinical Trial Optional)
(RFA-MH-25-190)
National Institute of Mental Health
Application Receipt Date(s): Multiple dates, see announcement.
-
Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed)
(RFA-RM-24-006)
Office of Strategic Coordination (Common Fund)
Application Receipt Date(s): Multiple dates, see announcement.
-
Single Source for the Continuation of the Data Management and Coordinating Center (DMCC) for Rare Diseases Clinical Research Network (RDCRN) (U2C Clinical Trial Not Allowed)
(RFA-TR-24-021)
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): Not Applicable
-
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
(RFA-TR-24-023)
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences
Application Receipt Date(s): Multiple dates, see announcement.